Tolerability and efficacy of pegylated consensus interferon-α in the treatment of chronic hepatitis C.

about

Tolerability and efficacy of pegylated consensus interferon-α in the treatment of chronic hepatitis C.

Item

http://www.wikidata.org/entity/Q37593837

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Tolerability and efficacy of p ...... atment of chronic hepatitis C.

@en

Tolerability and efficacy of p ...... atment of chronic hepatitis C.

@nl

type

Item

label

Tolerability and efficacy of p ...... atment of chronic hepatitis C.

@en

Tolerability and efficacy of p ...... atment of chronic hepatitis C.

@nl

prefLabel

Tolerability and efficacy of p ...... atment of chronic hepatitis C.

@en

Tolerability and efficacy of p ...... atment of chronic hepatitis C.

@nl

P1476

Tolerability and efficacy of p ...... atment of chronic hepatitis C.

@en

P2093

Bin Liu

http://www.w3.org/2001/XMLSchema#string

Cheng-Jiao Liu

http://www.w3.org/2001/XMLSchema#string

Hong Chen

http://www.w3.org/2001/XMLSchema#string

Hong Zhang

http://www.w3.org/2001/XMLSchema#string

Hua Luo

http://www.w3.org/2001/XMLSchema#string

Jun-Qi Niu

http://www.w3.org/2001/XMLSchema#string

Li Sun

http://www.w3.org/2001/XMLSchema#string

Qi Zhang

http://www.w3.org/2001/XMLSchema#string

Xin Zhang

http://www.w3.org/2001/XMLSchema#string

Yan-Fu Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Telaprevir for previously untreated chronic hepatitis C virus infection

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C.

Mixed vascular occlusion in a patient with interferon-associated retinopathy

P304

9-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2016.3914

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28123460

http://www.w3.org/2001/XMLSchema#string

P932

5244764

http://www.w3.org/2001/XMLSchema#string